About Recombinant Antibodies: Interview with Dr. Stefan Dübel

  Рет қаралды 363

PETA Science Consortium International e.V.

PETA Science Consortium International e.V.

Күн бұрын

Пікірлер: 1
@aruncm2580
@aruncm2580 3 жыл бұрын
Hi, I'm masters student from India, would like to know more about bacteriophage and how are the manifested in lab, like form screening the suitable phage, amplification and introducing them the possible activities. I would be glad if i could get a chance to interact you.
Reprogramming disease-driving cell states to fight disease
3:31
Vitamin D DANGERS (Must Know)
6:06
Dr. Eric Berg DC
Рет қаралды 226 М.
СИНИЙ ИНЕЙ УЖЕ ВЫШЕЛ!❄️
01:01
DO$HIK
Рет қаралды 3,3 МЛН
Tuna 🍣 ​⁠@patrickzeinali ​⁠@ChefRush
00:48
albert_cancook
Рет қаралды 148 МЛН
Use of computational approaches for pesticide toxicity assessment
1:29:45
PETA Science Consortium International e.V.
Рет қаралды 572
Frameworks for Establishing Scientific Confidence in New Approach Methodologies: Part 1
1:29:12
PETA Science Consortium International e.V.
Рет қаралды 561
In Vitro Phototoxicity Testing Part 1:  Methodological Overview
1:05:55
PETA Science Consortium International e.V.
Рет қаралды 270
Use of new approach methodologies to meet pesticide testing requirements in India
1:23:39
PETA Science Consortium International e.V.
Рет қаралды 518
Frameworks for Establishing Scientific Confidence in New Approach Methodologies: Part 2
1:32:31
PETA Science Consortium International e.V.
Рет қаралды 458
Use of in vitro skin irritation/corrosion test methods for the toxicity assessment of pesticides
1:44:25
PETA Science Consortium International e.V.
Рет қаралды 678
In Vitro Phototoxicity Testing Part 2: Application Case Studies
1:00:37
PETA Science Consortium International e.V.
Рет қаралды 151
Use of in vitro and ex vivo eye irritation corrosion test methods for the toxicity assess
1:28:03
PETA Science Consortium International e.V.
Рет қаралды 281
Is AI improving drug discovery?
4:25
OptibriumLtd
Рет қаралды 40
СИНИЙ ИНЕЙ УЖЕ ВЫШЕЛ!❄️
01:01
DO$HIK
Рет қаралды 3,3 МЛН